Health technology company Kalderos has made waves in the 340B world in recent years after emerging as a key player [...] …
Category: Federal
President Donald Trump’s recent executive order directing federal agencies to pursue “most favored nation” (MFN) pricing for prescription drugs could [...] …
A national 340B community health center organization, which has faced criticism for its partnership with a powerful drug industry trade [...] …
Hospitals that participate in the 340B program face more federal oversight and routinely see higher rates of compliance in federal [...] …
D.C. Federal District Court Dismisses Hospital Lawsuits Over J&J’s Controversial 340B Audit Requests
A Washington D.C. federal court this week threw out five hospital lawsuits challenging the Health Resources and Services Administration (HRSA) [...] …
Although the bulk of recent 340B-related legislative action has occurred in statehouses across the country, 340B advocates and stakeholders are [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
A Chicago-based pharmaceutical giant recently urged a federal court to block Colorado’s contract pharmacy access law—marking the first drug manufacturer [...] …
A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...] …
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...] …